Clinical Trial Update: Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide combined with high-dose dexamethasone in untreated multiple myeloma patients with renal failure; study status com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Renal Failure

Drugs mentioned

• lenalidomide + high-dose dexamethasone (lenalidomide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Renal Failure, Multiple Myeloma | Phase 2 | Status: COMPLETED